US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 799.800
  • +4.450+0.56%
Close Dec 2 16:00 ET
  • 801.310
  • +1.510+0.19%
Post 16:36 ET
759.26BMarket Cap86.46P/E (TTM)

About Eli Lilly and Co Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Company Profile

SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000

Company Executives

  • Name
  • Position
  • Salary
  • David A. Ricks
  • Chairman of the Board, President and Chief Executive Officer
  • 26.57M
  • Diogo Rau
  • Executive Vice President, Chief Information Officer and Chief Digital Officer
  • --
  • Donald A. Zakrowski
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Lucas Montarce
  • Executive Vice President and Chief Financial Officer
  • --
  • Alonzo Weems
  • Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
  • --
  • Dr. Daniel M. Skovronsky, M.D.
  • Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
  • 11.85M
  • Edgardo Hernandez
  • Executive Vice President and President, Manufacturing Operations
  • --
  • Eric Dozier
  • Executive Vice President, Human Resources and Diversity
  • --
  • Anne E. White
  • Executive Vice President and President, Lilly Neuroscience
  • --
  • Anat Hakim
  • Executive Vice President, General Counsel and Secretary
  • 7.01M
  • Ilya Yuffa
  • Executive Vice President and President, Lilly International
  • --
  • Patrik Jonsson
  • Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
  • --
  • Johna L. Norton
  • Executive Vice President, Global Quality
  • --
  • Jacob S. Van Naarden
  • Executive Vice President and President, Loxo
  • 4.89M
  • Juan R. Luciano
  • Lead Independent Director
  • 373.00K
  • Dr. Mary Lynne Hedley,PhD
  • Independent Director
  • 319.00K
  • Ralph Alvarez
  • Independent Director
  • 336.00K
  • Jon Moeller
  • Independent Director
  • --
  • Katherine Baicker
  • Independent Director
  • 336.00K
  • Jon Erik Fyrwald
  • Independent Director
  • 344.88K
  • Gabrielle Sulzberger, J.D.,M.B.A.
  • Independent Director
  • 335.50K
  • Karen Walker
  • Independent Director
  • 359.00K
  • Dr. William G. Kaelin, Jr
  • Independent Director
  • 349.15K
  • Kimberly H. Johnson
  • Independent Director
  • 316.00K
  • Jamere Jackson
  • Independent Director
  • 345.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data